PROM1 and neoplasm: CD133 has been reported to be a CSC marker in colorectal cancer[27,28], and, although some doubts have been arisen about its ability to specifically identify tumour-initiating cells[29], it has been widely used to identify and analyze CSC in colorectal cancers.